A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that peop...

Source: [ScienceDaily](https://www.sciencedaily.com/releases/2026/06/260615033837.htm)

Sponsored